Announcements

Stem Cell Network makes first direct biotech investment, awarding $1 million to Montreal-based RejuvenRx

Read Now
Stem Cell Network makes first direct biotech investment, awarding $1 million to Montreal-based RejuvenRx

Stem Cell Network makes first direct biotech investment, awarding $1 million to Montreal-based RejuvenRx

Read Now
Content is loading…

TMM News

Global leaders in regenerative medicine gather in Vancouver for the 2026 Till & McCulloch Meetings

November 9, 2026 

Nearly 450 researchers, clinicians, trainees, and industry leaders convene to share scientific advances, strengthen collaborations, and explore the future of regenerative medicine.

Insights Blog

Targeting Disease at the Source: A Conversation with Rising Researcher Dr. Songtao Dong

November 2, 2026 

In this Q&A with SCN, Dr. Dong shares highlights from his research, reflects on his career path and advice, and offers perspective on where the field of regenerative medicine is heading.

Insights Blog

Bold Science, Big Discoveries: Meet 2026 Till & McCulloch Award Winner Dr. Stephanie Xie

November 2, 2026 

In this Q&A with SCN, Dr. Xie shares highlights from her award-winning research, reflects on her career path and advice, and offers perspective on where the field of regenerative medicine is heading.

Insights Blog

From Possibility to Practice: Advancing Single-Cell Omics in Regenerative Medicine

October 26, 2026 

Regenerative medicine aims to restore or replace damaged or diseased tissues by harnessing the remarkable potential of cells to develop, adapt, and repair.

TMM News

Dr. Stephanie Xie receives 2026 Till & McCulloch Award for discovery of inflammatory memory in blood stem cells

October 15, 2026 

Dr. Stephanie Xie has been named the recipient of the 2026 Till & McCulloch Award for research revealing how inflammatory experiences can leave a lasting “memory” in human blood-forming stem cells.

Announcements

Stem Cell Network Welcomes Dr. Anthony Flamier to SCN-RDMM Catalyst Grant Program

September 28, 2026 

The Stem Cell Network (SCN) and the Rare Diseases: Models and Mechanisms Network (RDMM) are pleased to announce Dr. Anthony Flamier as the latest recipient of the SCN-RDMM Catalyst Grant.